George Bosl

Last updated

George Bosl (born 1948) is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. [1] [2] [3] [4] In 2019, he was named Memorial Sloan Kettering's first ombudsperson. [5]

Contents

Biography

Bosl earned his bachelor's degree at John Carroll University, in Cleveland, Ohio, and his M.D. at Creighton University School of Medicine in Omaha, Nebraska. [6] He trained in internal medicine at The New York Hospital and worked at Memorial Sloan Kettering Cancer Center as chief medical resident. He completed a fellowship in medical oncology at the University of Minnesota and then returned to Sloan Kettering to join the faculty in 1979. [7] At Memorial Sloan Kettering Cancer Center he has been director of the Oncology/Hematology training program, chief of the Genitourinary Oncology Service, head of the Division of Solid Tumor Oncology, and associate physician-in-chief before becoming chair of the Department of Medicine on February 1, 1997. [6] [8] [9]

He also heads the Joachim Silbermann Family Program on Aging and Cancer and has received grants from the National Institute of Health to study the sharp increase of older adults developing this disease. [10] [11]

Academic work

Bosl is a specialist in the treatment of genitourinary tumors particularly in testicular cancer. He is known for targeting a marker chromosome for Germ cell tumors. [12] [13] His studies investigate molecular targets of drug resistance in patients and developing dose-intensive chemotherapy and new chemotherapeutic agents, evaluating new combinations for patients with relapsing or resistant disease. [14] Some of his research is also centered on new therapies for head and neck cancers. [15] [16] [17] Bosl received many awards and honors, including the Patrick M. Byrne Chair in Clinical Oncology at MSKCC in 1995, the 2005 MSKCC Excellence in Medicine Award, the 2007 American Society of Clinical Oncology Statesman Award, the 2015 American Society of Clinical Oncology Distinguished Achievement Award, and the Mastership designation from the American College of Physicians in 2016. [18] [19] [20]

Related Research Articles

<span class="mw-page-title-main">Memorial Sloan Kettering Cancer Center</span> Hospital in New York City, US

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 52 National Cancer Institute–designated Comprehensive Cancer Centers. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.

Lawrence Einhorn is an American oncologist at Indiana University School of Medicine. A pioneer in cancer treatment research, Einhorn developed cisplatin-based chemotherapy regimens that increased cure rates while minimizing toxic side effects.

<span class="mw-page-title-main">Weill Cornell Medicine</span> Medical school of Cornell University

The Joan & Sanford I. Weill Medical College of Cornell University is Cornell University's biomedical research unit and medical school in New York City. It is affiliated with NewYork-Presbyterian Hospital, Weill Cornell Medical Center, Hospital for Special Surgery, Memorial Sloan Kettering Cancer Center, and Rockefeller University, all of which are located on or near York Avenue and Sutton Place.

Retroperitoneal lymph node dissection (RPLND) is a surgical procedure to remove abdominal lymph nodes. It is used to treat testicular cancer, as well as to help establish the exact stage and type of the cancer.

<span class="mw-page-title-main">José Baselga</span> Spanish oncologist (1959–2021)

Josep Baselga i Torres, known in Spanish as José Baselga, was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein, which is impacted in aggressive breast cancers.

William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.

Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.

Peter T. Scardino is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.

John H. Healey is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), as well as Professor of Surgery at Weill Cornell Medical College, in New York, NY.

<span class="mw-page-title-main">Kenneth Offit</span> American geneticist

Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College, and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.

Marcel R.M. van den Brink is a Dutch oncologist and researcher at Memorial Sloan Kettering Cancer Center known for his research in hematopoietic stem cell transplantation for cancer patients.

Howard I. Scher is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.

David A. Scheinberg is an American physician, scientist, drug developer, and entrepreneur, who is currently Vincent Astor Chair, and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.

Robert Maki is an American medical oncologist, Professor of Medicine at the Hospital of the University of Pennsylvania, He is a specialist in the management of and translational research regarding sarcoma, the group of connective tissue malignancies that include leiomyosarcoma, gastrointestinal stromal tumor (GIST), liposarcoma, angiosarcoma, Ewing sarcoma, desmoid tumor and many others.

Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.

Dr. Kathleen M. Foley is an American physician. She was an Attending Neurologist at Memorial Sloan-Kettering Cancer Center in New York City. She worked as a professor of Neurology, Neuroscience, and Clinical Pharmacology at Cornell University Weill Medical College. Foley made contributions toward making palliative care for cancer patients accessible. She headed the country's first pain service in a cancer center at Memorial Sloan-Kettering and was the medical director of the Supportive Care Program. In 1999, she became the director of the Open Society Institute’s Project on Death in America. Additionally, Foley was the Director of the WHO Collaborating Center for Cancer Pain Research and Education at Memorial Sloan-Kettering Cancer Center. She holds the Chair of the Society of Memorial Sloan-Kettering Cancer Center in Pain Research and continues to work with the Open Society Institute as the Medical Director of the International Palliative Care Initiative of the Network Public Health Program of the Research.

<span class="mw-page-title-main">Philip Kantoff</span> Medical researcher

Philip W. Kantoff is a medical oncologist. He is the chairman and chief executive officer (CEO) of Convergent Therapeutics. He served as the Chairman of Medicine at Memorial Sloan Kettering Cancer Center between 2015 and 2021. He is best known for his contributions to the impact of DNA abnormalities in prostate cancer and the discovery of therapies for metastatic hormone-sensitive prostate cancer.

<span class="mw-page-title-main">Lisa DeAngelis</span>

Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.

Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.

Bayard Delafield Clarkson Sr. is an American physician, hematologist, and oncologist.

References

  1. ↑ "Cancer Care Doctor: George J. Bosl, M.D." Memorial Sloan-Kettering Cancer Center. Retrieved February 18, 2013.
  2. ↑ "Nature Clinical Practice Oncology About the authors". Macmillan Publishers Limited.(2007) Vo. 4, No. 9, Pg. 508-509
  3. ↑ "Weill Cornell Medical College Faculty George J. Bosl, M.D., Professor of Medicine". Weill Cornell Medical College. Retrieved February 19, 2013.
  4. ↑ Printz, Carrie (February 2021). "First person profile: George J. Bosl, MD: Former long‐term chair of Memorial Sloan Kettering Cancer Center's Department of Medicine reflects on his multifaceted career". Cancer. 127 (3): 331–332. doi: 10.1002/cncr.33428 . PMID   33434337. S2CID   231588615.
  5. ↑ "Respected Physician and Researcher George J. Bosl Named Memorial Sloan Kettering's First Ombudsperson, a Confidential Resource for Staff | Memorial Sloan Kettering Cancer Center". www.mskcc.org.
  6. 1 2 "OncologySTAT Advisory Board". Elsevier. Retrieved February 18, 2013.
  7. ↑ "U.S. News Top Doctor". U.S. News & World Report. Retrieved February 19, 2013.
  8. ↑ "Creighton Medical School Taps Bosl for 2006 Alumni Award". Creighton University. Retrieved September 15, 2006.
  9. ↑ "Curing germ cell tumors after failure of high-dose chemotherapy: progress through clinical trials". Nature Clinical Practice Oncology. 4: 508–509. 2007. doi:10.1038/ncponc0904.
  10. ↑ Memorial Sloan-Kettering Cancer Center Joachim Silbermann Family Extends Support for Program in Aging & Cancer Archived 2013-03-08 at the Wayback Machine Retrieved on February 14, 2013.
  11. ↑ "Development of An Aging and Cancer Program at MSKCC". enGrant Scientific. 2003–2009. No. 5P20CA103694-05.
  12. ↑ Bosl, G.J.; Dmitrovsky, E.; Reuter, V.E.; Samaniego, F.; Rodroguez, E.; Geller, N.L.; Chaganti, R.S.K. (December 20, 1989). "Isochromosome of Chromosome 12: Clinically Useful Marker for Male Germ Cell Tumor". Journal of the National Cancer Institute. 81 (24): 1874–1878. doi:10.1093/jnci/81.24.1874. PMID   2556586.
  13. ↑ "2006 Alumni Merit Award Recipient". Creighton University. September 15, 2006.
  14. ↑ Ed Edelson "Repeat, High-Dose Chemo Can Cure Testicular". The Washington Post. July 25, 2007.
  15. ↑ Pfister, D.G., Harrison, L.B., Strong, EW., Shah, J.P., Spiro, R.W., Kraus, D.H., Armstrong, J.G., Zelefsky, M.J., Fass, D.E., Weiss, M.H., Wang, R.C., Schantz, S.P. and Bosl, G.J., Organ-Function preservation in Advanced Oropharynx Cancer: Results with Induction Chemotherapy and Radiation, Journal of Clinical Oncology, Vol. 13, No. 3, March, 1995: Pg. 671-680
  16. ↑ Elisabeth Rosenthal, "The Cancer War: A Major Advance", "The New York Times", October 8, 1989
  17. ↑ "Testicular Cancer seen as 'Stalking Horse' for Other Cancers". Journal of the National Cancer Institute. 91 (21): 1801–1803. 3 November 1999. doi: 10.1093/jnci/91.21.1801 .
  18. ↑ New ASCO Statesman Award Honors Meritorious Service and Contributions of Society Members Past and Present American Society of Clinical Oncology, Retrieved on February 26, 2013
  19. ↑ 2006-2007 Annual Report, American Society of Clinical Oncology Archived 2009-09-20 at the Wayback Machine Section 5, Pp. 37, Retrieved on February 26, 2013
  20. ↑ Printz, Carrie (February 2021). "First person profile: George J. Bosl, MD: Former long‐term chair of Memorial Sloan Kettering Cancer Center's Department of Medicine reflects on his multifaceted career". Cancer. 127 (3): 331–332. doi: 10.1002/cncr.33428 . PMID   33434337. S2CID   231588615.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.